1. 226. Higher Doses of Adintrevimab, an Extended Half-Life Monoclonal Antibody, for the Treatment and Prevention of COVID-19: Preliminary Results from a Phase 1 Single Ascending-Dose Study. (15th December 2022) Authors: Pu, Xia; Gong, Jean; Campanaro, Ed; Narayan, Kristin; Gupta, Deepali; Engler, Frank; Copans, Amanda; Schmidt, Pete Journal: Open forum infectious diseases Issue: Volume 9:(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Ledipasvir/sofosbuvir for treatment of hepatitis C virus in sofosbuvir‐experienced, NS5A treatment‐naïve patients: Findings from two randomized trials. (5th December 2017) Authors: Tam, Edward; Luetkemeyer, Anne F.; Mantry, Parvez S.; Satapathy, Sanjaya K.; Ghali, Peter; Kang, Minhee; Haubrich, Richard; Shen, Xianlin; Ni, Liyun; Camus, Gregory; Copans, Amanda; Rossaro, Lorenzo; Guyer, Bill; Brown, Robert S. Journal: Liver international Issue: Volume 38:Number 6(2018) Page Start: 1010 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗